Abstract:Objective To study the expression and clinical significance of human mammoglobin (hMAM) mRNA and CD44V6 mRNA, and to evaluate the possibility of hMAM mRNA and CD44V6 mRNA as a tumor marker of micrometastasis in breast cancer. Methods Expressions of hMAM mRNA and CD44V6 mRNA were detected in samples of breast cancer and adjacent non-tumoral tissues, benign breast tumor and in peripheral blood from patients with breast cancer and breast benign lesions, and healthy volunteers by nested reverse transcription polymerase chain reaction (nested-RT-PCR), and other cancers (including gastric carcinomas,colorectal carcinomas, esophageal carcinomas, lung carcinomas, and ovary carcinomas) were analyzed for hMAM-mRNA expression by nested-RT-PCR method. Results The positive rates of hMAM mRNA were 96. 72%, 96. 72% and 93. 75% in breast cancer, corresponding normal tissues and breast benign tumor, there was no significant difference from them (P0. 05). hMAM mRNA was not expressed in other cancers. The expression of CD44V6 mRNA was significantly higher than that of adjacent non-tumoral tissues and benign breast tumor. The positive expression rate of hMAM mRNA was 45. 90% in peripheral blood from patients with breast cancer, and the positive rate of hMAM mRNA in peripheral blood of breast cancer patients with stage Ⅳ was significantly higher than those patients with stage Ⅰ ,Ⅱ and Ⅲ (P 0. 05). No hMAM mRNA expression was found in peripheral blood of patients with breast benign lesions or healthy volunteers. The positive expression of CD44V6 mRNA was 83. 61%, 81. 25% and 80. 00% in peripheral blood of patients with breast cancer, breast benign lesions, and healthy volunteers, respectively. No significant difference was found among three groups(P 0. 05). Conclusion hMAM mRNA is specific expression in breast tissue, and the positive expression of hMAM mRNA in peripheral blood might predict hematogenous metastatic spreading of tumor cells, and hMAM mRNA may be potential biological marker for detecting breast cancer micrometastasis. CD44V6 mRNA as a marker of mammary carcinoma cells in peripheral blood is lack of specificity.

Clinical significance of MUC1 mRNA detection in bone marrow of breast cancer patients

Integrated Bioinformatics Analysis and Clinical Validation Reveals That High Expression of Mucin 1 in Intrahepatic Cholangiocarcinoma Predicts Recurrence after Curative Resection.

Clinicopathological and Prognostic Significance of MUC4 Expression in Cancers: Evidence from Meta-Analysis.

Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis.

[Association of Bmi-1 Expression with Clinicopathological Features and Prognosis of Colorectal Cancer].

Expression of MDR1mRNA detected and its correlation with p53 in esophageal carcinoma by in situ hybridization

Expression and clinical significance of Bmi-1 in colorectal cancer

RRM1, TUBB3, TOP2A, CYP19A1, CYP2D6: Difference Between Mrna and Protein Expression in Predicting Prognosis of Breast Cancer Patients

Expression and Clinical Significance of Tumor Associated Antigen MUC1 and Its Isoform MUC1/Y mRNA in Bladder Cancer

MUC1-positive Circulating Tumor Cells and MUC1 Protein Predict Chemotherapeutic Efficacy in the Treatment of Metastatic Breast Cancer.

Expression of Mucin Family Proteins in Non-Small-Cell Lung Cancer and Its Role in Evaluation of Prognosis

[Expression of Small Breast Epithelial Mucin Mrna in Peripheral Blood of Breast Cancer Patients and Its Clinical Significance].

Detection and Clinical Significance of Hmam Mrna-Positive Circulating Tumor Cells in Early Breast Cancer

[Correlation of the Expression of III Β-Tubulin and MDR1 Protein with Biological Features of Non-Small Cell Lung Cancer].

Expression of MUC1 in different tumours and its clinical significance (Review)

Expression of FS,MUC1 Proteins in the Breast Cancer Patients Serum and the Clinical Significance

Expressions of Hmam Mrna and CD44V6 Mrna in Breast Cancer

Significance of breast cancer specific gene 1 expression in breast cancer

The recent history of the X‐ray absorber in NGC 3516

MUC1 Overexpression Predicts Worse Survival in Patients with Non-Small Cell Lung Cancer: Evidence from an Updated Meta-Analysis.

Human Mammaglobin: a Superior Marker for Reverse-Transcriptase PCR in Detecting Circulating Tumor Cells in Breast Cancer Patients